SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-21-096597
Filing Date
2021-03-26
Accepted
2021-03-26 16:28:37
Documents
7
Effectiveness Date
2021-03-26

Document Format Files

Seq Description Document Type Size
1 S-8 d101803ds8.htm S-8 75726
2 EX-4.5 d101803dex45.htm EX-4.5 268456
3 EX-4.6 d101803dex46.htm EX-4.6 75857
4 EX-5.1 d101803dex51.htm EX-5.1 7936
5 EX-23.1 d101803dex231.htm EX-23.1 1452
6 GRAPHIC g101803g17v72.jpg GRAPHIC 5216
7 GRAPHIC g101803g71l30.jpg GRAPHIC 3200
  Complete submission text file 0001193125-21-096597.txt   442306
Mailing Address 200 INNER BELT ROAD SOMERVILLE MA 02143
Business Address 200 INNER BELT ROAD SOMERVILLE MA 02143 617-229-6499
Finch Therapeutics Group, Inc. (Filer) CIK: 0001733257 (see all company filings)

IRS No.: 823433558 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-254773 | Film No.: 21777782
SIC: 2836 Biological Products, (No Diagnostic Substances)